10-30439172-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_005204.4(MAP3K8):c.234T>C(p.Tyr78Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.559 in 1,613,878 control chromosomes in the GnomAD database, including 263,489 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.45 ( 18559 hom., cov: 33)
Exomes 𝑓: 0.57 ( 244930 hom. )
Consequence
MAP3K8
NM_005204.4 synonymous
NM_005204.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.69
Publications
76 publications found
Genes affected
MAP3K8 (HGNC:6860): (mitogen-activated protein kinase kinase kinase 8) This gene is an oncogene that encodes a member of the serine/threonine protein kinase family. The encoded protein localizes to the cytoplasm and can activate both the MAP kinase and JNK kinase pathways. This protein was shown to activate IkappaB kinases, and thus induce the nuclear production of NF-kappaB. This protein was also found to promote the production of TNF-alpha and IL-2 during T lymphocyte activation. This gene may also utilize a downstream in-frame translation start codon, and thus produce an isoform containing a shorter N-terminus. The shorter isoform has been shown to display weaker transforming activity. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 10-30439172-T-C is Benign according to our data. Variant chr10-30439172-T-C is described in ClinVar as Benign. ClinVar VariationId is 1174756.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.68 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.601 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.452 AC: 68768AN: 151978Hom.: 18567 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
68768
AN:
151978
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.513 AC: 129081AN: 251414 AF XY: 0.513 show subpopulations
GnomAD2 exomes
AF:
AC:
129081
AN:
251414
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.570 AC: 833223AN: 1461782Hom.: 244930 Cov.: 52 AF XY: 0.565 AC XY: 410633AN XY: 727182 show subpopulations
GnomAD4 exome
AF:
AC:
833223
AN:
1461782
Hom.:
Cov.:
52
AF XY:
AC XY:
410633
AN XY:
727182
show subpopulations
African (AFR)
AF:
AC:
4540
AN:
33480
American (AMR)
AF:
AC:
23957
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
13654
AN:
26134
East Asian (EAS)
AF:
AC:
16097
AN:
39698
South Asian (SAS)
AF:
AC:
30993
AN:
86254
European-Finnish (FIN)
AF:
AC:
32686
AN:
53420
Middle Eastern (MID)
AF:
AC:
2571
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
676250
AN:
1111912
Other (OTH)
AF:
AC:
32475
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
20107
40213
60320
80426
100533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
17948
35896
53844
71792
89740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.452 AC: 68774AN: 152096Hom.: 18559 Cov.: 33 AF XY: 0.450 AC XY: 33465AN XY: 74338 show subpopulations
GnomAD4 genome
AF:
AC:
68774
AN:
152096
Hom.:
Cov.:
33
AF XY:
AC XY:
33465
AN XY:
74338
show subpopulations
African (AFR)
AF:
AC:
6435
AN:
41526
American (AMR)
AF:
AC:
7866
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
1773
AN:
3470
East Asian (EAS)
AF:
AC:
1909
AN:
5162
South Asian (SAS)
AF:
AC:
1598
AN:
4824
European-Finnish (FIN)
AF:
AC:
6350
AN:
10558
Middle Eastern (MID)
AF:
AC:
142
AN:
294
European-Non Finnish (NFE)
AF:
AC:
41178
AN:
67962
Other (OTH)
AF:
AC:
1003
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1649
3298
4948
6597
8246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
616
1232
1848
2464
3080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1207
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sep 04, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.